10,422 results
Search Results
202. Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRASG13D mutation
203. M2 macrophages mediate sorafenib resistance by secreting HGF in a feed-forward manner in hepatocellular carcinoma
204. Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment
205. A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas
206. Anti-angiogenic effects of crenolanib are mediated by mitotic modulation independently of PDGFR expression
207. The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma
208. Case–control study of paternal occupational exposures and childhood lymphoma in Great Britain, 1962–2010
209. CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
210. The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution
211. Predictive value of inflammatory markers for cancer diagnosis in primary care: a prospective cohort study using electronic health records
212. Low tumour PPM1H indicates poor prognosis in colorectal cancer via activation of cancer-associated fibroblasts
213. LGR5 expression predicts peritoneal recurrence after curative resection of primary colon cancer
214. Understanding the impact of socioeconomic differences in colorectal cancer survival: potential gain in life-years
215. Coffee consumption by type and risk of digestive cancer: a large prospective cohort study
216. Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study
217. Reproductive factors, exogenous hormone use and incidence of melanoma among women in the United States
218. The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies
219. Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α
220. Effect of increased body mass index on risk of diagnosis or death from cancer
221. Genome-wide association study of germline variants and breast cancer-specific mortality
222. Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs
223. Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention
224. Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas
225. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study
226. Age alone is not a barrier to efficacy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: analysis of 1138 patients from the UK and Ireland Colorectal Peritoneal Metastases Registry
227. Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial
228. Patient attrition in Molecular Tumour Boards: a systematic review
229. Heritability of childhood leukaemia and non-Hodgkin lymphoma.
230. Impact of lymph node metastasis on immune microenvironment and prognosis in colorectal cancer liver metastasis: insights from multiomics profiling: Clinical Studies
231. Oxaliplatin induces pyroptosis in hepatoma cells and enhances antitumor immunity against hepatocellular carcinoma: Translational Therapeutics
232. Breast cancer metastasis progression is associated with elevated activity of kynurenine monooxygenase and kynureninase: Cellular and Molecular Biology
233. Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer: Genetics and Genomics
234. Phenotypical differences of neutrophils patrolling tumour-draining lymph nodes in head and neck cancer: Cellular and Molecular Biology
235. Height and breast cancer risk in premenopausal Korean women aged under 40 years of age: Epidemiology
236. Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in pancreatic cancer: Translational Therapeutics
237. Temporal dynamics of immune cell patterns in bladder cancer patients receiving Bacillus Calmette-Guérin therapy: Clinical Studies
238. Pro-survival roles for p21(Cip1/Waf1) in non-small cell lung cancer: Cellular and Molecular Biology
239. Reproductive factors and risk of epithelial ovarian cancer: results from the Asia Cohort Consortium: Epidemiology
240. Targeting PTGDS Promotes ferroptosis in peripheral T cell lymphoma through regulating HMOX1-mediated iron metabolism: Translational Therapeutics
241. The accuracy of fluorine 18-labelled prostate-specific membrane antigen PET/CT and MRI for diagnosis of prostate cancer in PSA grey zone: Clinical Studies
242. Women’s perspectives of molecular breast imaging: a qualitative study: Epidemiology
243. Dietary intake of isoflavones and coumestrol and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial: Epidemiology
244. Identification of diagnostic biomarkers in prostate cancer-related fatigue by construction of predictive models and experimental validation: Molecular Diagnostics
245. Non-B DNA-informed mutation burden as a marker of treatment response and outcome in cancer
246. Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma
247. Identification of a 5-gene signature panel for the prediction of prostate cancer progression
248. The potential clinical utility of Whole Genome Sequencing for patients with cancer: evaluation of a regional implementation of the 100,000 Genomes Project
249. Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma
250. Crucial immunological roles of the invasion front in innate and adaptive immunity in cervical cancer
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.